ChemicalBook >> CAS DataBase List >>LLL12

LLL12

CAS No.
1260247-42-4
Chemical Name:
LLL12
Synonyms
LLL12;LLL-12 (LLL12;5-hydroxy-9,10-dioxo-9,10-dihydroanthracene-1-sulfonamide;1-Anthracenesulfonamide, 9,10-dihydro-5-hydroxy-9,10-dioxo-
CBNumber:
CB32731095
Molecular Formula:
C14H9NO5S
Molecular Weight:
303.29
MDL Number:
MOL File:
1260247-42-4.mol
Last updated:2025-04-18 09:52:05

LLL12 Properties

Melting point 179-181 °C
Boiling point 618.2±65.0 °C(Predicted)
Density 1.626±0.06 g/cm3(Predicted)
pka 6.46±0.20(Predicted)
form Solid
color Light yellow to yellow

LLL12 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Usbiological L2652-01 LLL12 1260247-42-4 5mg $360 2021-12-16 Buy
Product number Packaging Price Buy
L2652-01 5mg $360 Buy

LLL12 Chemical Properties,Uses,Production

Description

LLL12 is a potent STAT3 inhibitor. LLL12 inhibits colony formation and cell migration and works synergistically with doxorubicin and gemcitabine. LLL12 demonstrated a potent inhibitory activity on breast and glioblastoma tumor growth in a mouse xenograft model. LLL12 may be a potential therapeutic agent for human cancer cells expressing constitutive STAT3 signaling.

Uses

LLL12 is a small molecule inhibitor of STAT3 that inhibits STAT3 phosphorylation. LLL12 enhanced the inhibitory effect of Cisplatin (HY-17394) and Paclitaxel (HY-B0015) on ovarian cancer cell formation, migration, and growth[1].

in vivo

LLL12 (5 mg/kg; i.p.; once daily for 13 d) shows strong growth inhibition activity in mouse osteosarcoma cells and tumor growth[2].

Animal Model:Mouse xenografts with SJSA or OS-33 osteosarcoma cells[2]
Dosage:5 mg/kg
Administration: Intraperitoneal injection; once daily for 13 days
Result:Resulted in a significant reduction in tumor volume and tumor mass in the OS-33 and SJSA xenografted mice.

IC 50

p-STAT3

References

[1] Zhang R, et al. A small molecule STAT3 inhibitor, LLL12, enhances cisplatin? and paclitaxel?mediated inhibition of cell growth and migration in human ovarian cancer cells. Oncol Rep. 2020 Sep;44(3):1224-1232. DOI:10.3892/or.2020.7667
[2] Onimoe GI, et al. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice. Invest New Drugs. 2012 Jun;30(3):916-26. DOI:10.1007/s10637-011-9645-1

LLL12 Preparation Products And Raw materials

Raw materials

Preparation Products

LLL12 Suppliers

Global( 29)Suppliers
Supplier Tel Email Country ProdList Advantage
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6312 58
TargetMol Chemicals Inc.
+8613564774135 zijue.cai@tsbiochem.com United States 19881 58
SHANGHAI FORTUNE CHEMICAL TECHNOLOGY CO., LTD 13816107857 sales@fortunechem-sh.com China 825 58
Suzhou yacoo science co.,Ltd 0512-87182056 18013166090 lingling.qi@yacoo.com.cn China 7295 60
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24641 58
Chengdu Peter-like Biotechnology Co., Ltd. 028-81700200 13308200041 2851167782@qq.com China 11183 58
Nanjing Shizhou Biology Technology Co.,Ltd 025-85560043 15850508050 cindy.huang@synzest.com China 12000 58

View Lastest Price from LLL12 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
LLL12 pictures 2024-11-19 LLL12
1260247-42-4
US $1230.00-1870.00 / mg 10g TargetMol Chemicals Inc.
  • LLL12 pictures
  • LLL12
    1260247-42-4
  • US $1230.00-1870.00 / mg
  • TargetMol Chemicals Inc.
LLL12 LLL-12 (LLL12 5-hydroxy-9,10-dioxo-9,10-dihydroanthracene-1-sulfonamide 1-Anthracenesulfonamide, 9,10-dihydro-5-hydroxy-9,10-dioxo- 1260247-42-4